(Q37933057)

25 August 2017

1 reference

title

Molecular insight into invasive group A streptococcal disease (English)

1 reference

25 August 2017

3

1 reference

25 August 2017

Mark J Walker

4

0 references

author name string

Jason N Cole

series ordinal

1

1 reference

PubMed ID

21921933

25 August 2017

Timothy C Barnett

series ordinal

2

1 reference

PubMed ID

21921933

25 August 2017

language of work or name

English

0 references

publication date

16 September 2011

1 reference

Nature Reviews Microbiology

25 August 2017

1 reference

25 August 2017

9

1 reference

25 August 2017

10

1 reference

25 August 2017

724-736

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro2648

25 August 2017

0 references

cites work

The global burden of group A streptococcal diseases

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Necrotizing fasciitis: pathogenesis and treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Human pathogenic streptococcal proteomics and vaccine development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Group A Streptococcal Pharyngitis Serotype Surveillance in North America, 2000–2002

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Global emm type distribution of group A streptococci: systematic review and implications for vaccine development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Rise and persistence of global M1T1 clone of Streptococcus pyogenes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

New understanding of the group A Streptococcus pathogenesis cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Evolutionary Origin and Emergence of a Highly Successful Clone of Serotype M1 Group A Streptococcus Involved Multiple Horizontal Gene Transfer Events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Trigger for group A streptococcal M1T1 invasive disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Epidemiology of severe Streptococcus pyogenes disease in Europe.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Streptococcus adherence and colonization.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The intracellular status of Streptococcus pyogenes: role of extracellular matrix-binding proteins and their regulation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Neutrophil extracellular traps kill bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Streptococcus pyogenes bacteria modulate membrane traffic in human neutrophils and selectively inhibit azurophilic granule fusion with phagosomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Intranasal Immunization with Recombinant Group A Streptococcal M Protein Fragment Fused to the B Subunit of Escherichia coli Labile Toxin Protects Mice against Systemic Challenge Infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Collagen VI is a subepithelial adhesive target for human respiratory tract pathogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Hyaluronic acid synthesis operon (has) expression in group A streptococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in gram-positive bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Cytolysin-dependent evasion of lysosomal killing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Autophagy defends cells against invading group A Streptococcus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Cytolysins augment superantigen penetration of stratified mucosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Role of streptolysin O in a mouse model of invasive group A streptococcal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Incompetence of neutrophils to invasive group A streptococcus is attributed to induction of plural virulence factors by dysfunction of a regulator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The secreted esterase of group a streptococcus is important for invasive skin infection and dissemination in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Use of the plasminogen activation system by microorganisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

ECM and cell surface proteolysis: regulating cellular ecology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinase-independent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Plasminogen is a critical host pathogenicity factor for group A streptococcal infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Plasminogen-mediated group A streptococcal adherence to and pericellular invasion of human pharyngeal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Role of the C-terminal lysine residues of streptococcal surface enolase in Glu- and Lys-plasminogen-binding activities of group A streptococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Defining the structural basis of human plasminogen binding by streptococcal surface enolase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Capturing host plasmin(ogen): a common mechanism for invasive pathogens?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Mechanisms of plasminogen activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Is plasminogen deployed as a Streptococcus pyogenes virulence factor?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The SpeB virulence factor of Streptococcus pyogenes, a multifunctional secreted and cell surface molecule with strepadhesin, laminin-binding and cysteine protease activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Regulation of SpeB in Streptococcus pyogenes by pH and NaCl: a model for in vivo gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Selective modulation of superantigen-induced responses by streptococcal cysteine protease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

A naturally occurring mutation in ropB suppresses SpeB expression and reduces M1T1 group A streptococcal systemic virulence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

RscA, a member of the MDR1 family of transporters, is repressed by CovR and required for growth of Streptococcus pyogenes under heat stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

CovS inactivates CovR and is required for growth under conditions of general stress in Streptococcus pyogenes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Streptococcus pyogenes CovRS mediates growth in iron starvation and in the presence of the human cationic antimicrobial peptide LL-37.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The CsrR/CsrS two-component system of group A Streptococcus responds to environmental Mg2+

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The two faces of Janus: virulence gene regulation by CovR/S in group A streptococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Dissection of the molecular basis for hypervirulence of an in vivo-selected phenotype of the widely disseminated M1T1 strain of group A Streptococcus bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Microevolution of group A streptococci in vivo: capturing regulatory networks engaged in sociomicrobiology, niche adaptation, and hypervirulence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Streptococcal necrotising fasciitis from diverse strains of Streptococcus pyogenes in tropical northern Australia: case series and comparison with the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Characterization of a mouse-passaged, highly encapsulated variant of group A streptococcus in in vitro and in vivo studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A streptococcus clinical isolate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Parameters governing invasive disease propensity of non-M1 serotype group A streptococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Serotype- and strain- dependent contribution of the sensor kinase CovS of the CovRS two-component system to Streptococcus pyogenes pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Characterization of biofilm formation by clinically relevant serotypes of group A streptococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Detection of invasive protein profile of Streptococcus pyogenes M1 isolates from pharyngitis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

An insert in the covS gene distinguishes a pharyngeal and a blood isolate of Streptococcus pyogenes found in the same individual

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Complete genome sequence of an M1 strain of Streptococcus pyogenes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Burden of Acute Sore Throat and Group A Streptococcal Pharyngitis in School-aged Children and Their Families in Australia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Prospective surveillance of streptococcal sore throat in a tropical country

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Management of common bacterial infections of the skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Impetigo: incidence and treatment in Dutch general practice in 1987 and 2001--results from two national surveys.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

High burden of impetigo and scabies in a tropical country

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Prevention and treatment of rheumatic heart disease in the developing world

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

School-based prevention of acute rheumatic fever: a group randomized trial in New Zealand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The persistent challenge of rheumatic fever in the Northern Mariana Islands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Acute poststreptococcal glomerulonephritis: an update.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Gram-positive toxic shock syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

The immunology of sepsis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Invasive group A streptococcus infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Maternal sepsis: epidemiology, etiology and outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2648

Diagnosis and treatment of streptococcal pharyngitis.

31 March 2020

1 reference

12 December 2020

Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia.

1 reference

12 December 2020

Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion

1 reference

12 December 2020

The burden of group A streptococcal pharyngitis in Melbourne families.

1 reference

12 December 2020

A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B.

1 reference

12 December 2020

Substitution of cysteine 192 in a highly conserved Streptococcus pyogenes extracellular cysteine protease (interleukin 1beta convertase) alters proteolytic activity and ablates zymogen processing.

1 reference

12 December 2020

Bacterial plasminogen activators and receptors

1 reference

12 December 2020

Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus.

1 reference

12 December 2020

Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci

1 reference

12 December 2020

The epidemiology of invasive group A streptococcal disease in Victoria, Australia.

1 reference

12 December 2020

Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci

1 reference

12 December 2020

Group A streptococcal sore throat in a periurban population of northern India: a one-year prospective study.

1 reference

12 December 2020

Outcome of an interventional program for scabies in an Indigenous community.

1 reference

12 December 2020

Mechanism of membrane damage by streptolysin-O.

1 reference

12 December 2020

Occurrence of mucoid M-18 Streptococcus pyogenes in a central Ohio pediatric population

1 reference

12 December 2020

M protein mediated adhesion of M type 24 Streptococcus pyogenes stimulates release of interleukin-6 by HEp-2 tissue culture cells

1 reference

12 December 2020

Plasminogen activation by invasive human pathogens

1 reference

12 December 2020

Pathogenesis of group A streptococcal infections

1 reference

12 December 2020

PAM, a novel plasminogen-binding protein from Streptococcus pyogenes.

1 reference

12 December 2020

Role of fibrinogen in complement inhibition by streptococcal M protein

1 reference

12 December 2020

Invasive group A streptococcal disease in North Queensland (1996 - 2001).

1 reference

12 December 2020

Epidemiology of rheumatic fever and rheumatic heart disease in a rural community in northern India.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO2648

1 reference

25 August 2017

1 reference

PubMed ID

21921933